Abstract:The incidence and mortality rate of cancer has been quickly increasing in the past decades. At present, cancer has become the leading cause of death worldwide. Most of the cancers cannot be effectively diagnosed at the early stage. Although there are multiple therapeutic treatments, including surgery, radiotherapy, chemotherapy, and targeted drugs, their effectiveness is still limited. The overall survival rate of malignant cancers is still low. It is necessary to further study the mechanisms for malignant cancers, and explore new biomarkers and targets that are more sensitive and effective for early diagnosis, treatment, and prognosis of cancers than traditional biomarkers and methods. Long non-coding RNAs (lncRNAs) are a class of RNA transcripts with a length greater than 200 nucleotides. Generally, lncRNAs are not capable of encoding proteins or peptides. LncRNAs exert diverse biological functions by regulating gene expressions and functions at transcriptional, translational, and post-translational levels. In the past decade, it has been demonstrated that the dysregulated lncRNA profile is widely involved in the pathogenesis of many diseases, including cancer, metabolic disorders, and cardiovascular diseases. In particular, lncRNAs have been revealed to play an important role in tumor growth and metastasis. Many lncRNAs have been shown to be potential biomarkers and targets for the diagnosis and treatment of cancers. This review aims to briefly discuss the latest findings regarding the roles and mechanisms of some important lncRNAs in the pathogenesis of certain malignant cancers, including lung, breast, liver, and colorectal cancers, as well as hematological malignancies and neuroblastoma.

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

Long Noncoding RNA: Its Partners and Their Roles in Cancer

Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.

LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.

The Application Of Lncrnas In Cancer Treatment And Diagnosis

Biological functions and clinical significance of long noncoding RNAs in bladder cancer

Circulating Long Non-Coding RNAs in Cancer: Current Status and Future Perspectives

Role of Cytoplasmic Lncrnas in Regulating Cancer Signaling Pathways

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects

Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer

Long Non-Coding RNA in the Pathogenesis of Cancers

Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation

Differential expression of lone non-coding RNAs as diagnostic markers for lung cancer and other malignant tumors

Long Non-Coding Rnas in Non-Small Cell Lung Cancer As Biomarkers and Therapeutic Targets

Long non-coding RNA in tumor diagnosis

Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis

The Potential of Long Noncoding RNAs for Precision Medicine in Human Cancer

Pathological Bases and Clinical Impact of Long Noncoding RNAs in Prostate Cancer: a New Budding Star

Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer.